Performance analysis of THNR (Amplify Weight Loss Drug & Treatment ETF)
Annual Return
Since May 21, 2024, THNR has had an average annual return of +1.74%, underperforming the benchmark SPY, which returned +18.56% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +1.88% | +13.65% | -10.35% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.90% | -0.93% | -5.30% | -0.36% | +1.75% | +3.08% | +0.02% | +1.88% | |||||
| 2025 | +2.58% | +1.50% | -8.27% | +2.27% | +1.03% | +2.02% | -1.12% | +2.13% | +2.10% | -0.45% | +11.62% | -1.45% | +13.65% |
| 2024 | -0.26% | +2.91% | +1.03% | +7.05% | -4.94% | -5.64% | -5.03% | -5.20% | -10.35% |
Drawdown analysis of THNR (Amplify Weight Loss Drug & Treatment ETF)
The maximum drawdown for the THNR was -32.50%, occurring on Apr 8, 2025. This drawdown has not yet recovered.
The current THNR drawdown is -6.49%.
Since May 21, 2024 THNR has experienced the following drawdowns:
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -32.50% | Aug 30, 2024 | 150 | Apr 8, 2025 | Ongoing | Ongoing | Ongoing |
| -6.89% | Jul 12, 2024 | 18 | Aug 7, 2024 | 6 | Aug 15, 2024 | 24 |
| -1.81% | May 21, 2024 | 5 | May 29, 2024 | 3 | Jun 3, 2024 | 8 |
| -1.57% | Jun 25, 2024 | 6 | Jul 3, 2024 | 4 | Jul 10, 2024 | 10 |
| -1.10% | Jun 10, 2024 | 6 | Jun 18, 2024 | 3 | Jun 24, 2024 | 9 |
| -0.49% | Aug 23, 2024 | 1 | Aug 26, 2024 | 3 | Aug 29, 2024 | 4 |
| -0.19% | Aug 15, 2024 | 1 | Aug 16, 2024 | 1 | Aug 19, 2024 | 2 |